- Search results for 1640282-42-3
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "1640282-42-3"!
Close filters
Filter by:
No results were found for the filter!
Item number: Cay41863-1
Zunsemetinib is a p38alpha MAPK inhibitor biased toward MAPK-activated protein kinase 2 (MK2). It selectively inhibits p38alpha MAPK-dependent activation of MK2 over p38alpha MAPK-dependent activation of MK5, also known as p38-regulated/activated protein kinase (PRAK), and p38alpha MAPK-dependent activation of...
Keywords: | ATI-450, CDD-450,... |
Application: | MK2-biased p38alpha MAPK inhibitor |
CAS | 1640282-42-3 |
MW: | 513.9 D |
From 200.00€
*
Item number: TGM-T39126-100mg
Description: Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38alpha mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis. Target: MAPK. Smiles:...
Keywords: | CDD-450, ATI-450 |
Application: | Targets mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1] (MAPKAPK2) |
CAS | 1640282-42-3 |
MW: | 513.92 D |
From 281.00€
*